AIG Japan Holdings Kabushiki Kaisha:企業の戦略・SWOT・財務分析

◆英語タイトル:AIG Japan Holdings Kabushiki Kaisha - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5208
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

AIG Japan Holdings Kabushiki Kaisha – Strategy, SWOT and Corporate Finance Report
Summary

AIG Japan Holdings Kabushiki Kaisha – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

AIG Japan Holdings Kabushiki Kaisha (AIG Japan), a subsidiary of American International Group, Inc. (AIG), is an insurance holding company. The company, through its subsidiaries, offers a range of insurance products and services and other related operations to its clients. It offers insurance products for travel and leisure, motor, property, fire, medical, accident, liability, and managers and officials, and accident. Through these products, the company caters to individuals and corporate customers. It also offers business management services to AIG companies in Japan. It markets and distributes its products through a network of its sales offices and agencies. The company is headquartered in Tokyo, Japan.

Scope

- Detailed information on AIG Japan Holdings Kabushiki Kaisha required for business and competitor intelligence needs
- A study of the major internal and external factors affecting AIG Japan Holdings Kabushiki Kaisha in the form of a SWOT analysis
- An in-depth view of the business model of AIG Japan Holdings Kabushiki Kaisha including a breakdown and examination of key business segments
- Intelligence on AIG Japan Holdings Kabushiki Kaisha’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about AIG Japan Holdings Kabushiki Kaisha, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of AIG Japan Holdings Kabushiki Kaisha and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess AIG Japan Holdings Kabushiki Kaisha as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on AIG Japan Holdings Kabushiki Kaisha’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
AIG Japan Holdings Kabushiki Kaisha: Company Overview
AIG Japan Holdings Kabushiki Kaisha: Overview and Key Facts
AIG Japan Holdings Kabushiki Kaisha: Overview
AIG Japan Holdings Kabushiki Kaisha: Key Facts
AIG Japan Holdings Kabushiki Kaisha: Key Employees
AIG Japan Holdings Kabushiki Kaisha: Major Products and Services
AIG Japan Holdings Kabushiki Kaisha: Company History
AIG Japan Holdings Kabushiki Kaisha: Management Statement
AIG Japan Holdings Kabushiki Kaisha: Locations and Subsidiaries
AIG Japan Holdings Kabushiki Kaisha: Key Competitors
AIG Japan Holdings Kabushiki Kaisha: Company Analysis
AIG Japan Holdings Kabushiki Kaisha: Business Description
AIG Japan Holdings Kabushiki Kaisha: SWOT Analysis
AIG Japan Holdings Kabushiki Kaisha: SWOT Overview
AIG Japan Holdings Kabushiki Kaisha: Strengths
AIG Japan Holdings Kabushiki Kaisha: Weaknesses
AIG Japan Holdings Kabushiki Kaisha: Opportunities
AIG Japan Holdings Kabushiki Kaisha: Threats
AIG Japan Holdings Kabushiki Kaisha: Recent Developments
AIG Japan Holdings Kabushiki Kaisha: News and Events Summary
AIG Japan Holdings Kabushiki Kaisha: Corporate Governance
AIG Japan Holdings Kabushiki Kaisha: Financial Deals
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: AIG Japan Holdings Kabushiki Kaisha: Key Facts
Table 2: AIG Japan Holdings Kabushiki Kaisha: Key Employees
Table 3: AIG Japan Holdings Kabushiki Kaisha: Company History
Table 4: AIG Japan Holdings Kabushiki Kaisha: Locations and Subsidiaries
Table 5: AIG Japan Holdings Kabushiki Kaisha: Key Competitors
Table 6: AIG Japan Holdings Kabushiki Kaisha: News and Events Summary
Table 7: AIG Japan Holdings Kabushiki Kaisha: Corporate Governance
Table 8: AIG Japan Holdings Kabushiki Kaisha: Financial Deals

★海外企業調査レポート[AIG Japan Holdings Kabushiki Kaisha:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ossur hf (OSSR)-医療機器分野:企業M&A・提携分析
    Summary Ossur hf. (Ossur) is an orthopedic devices company. It develops, manufactures and sells prosthetics, and bracing and support products. The company’s key areas of expertise include silicone, carbon composites, mechatronics and textiles. Ossur offers ankle and foot supports, knee braces, neck …
  • UCB SA (UCB)-医療機器分野:企業M&A・提携分析
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Centers for Disease Control and Prevention-製薬・医療分野:企業M&A・提携分析
    Summary Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities f …
  • NCC Ltd (NCC):企業の財務・戦略的SWOT分析
    NCC Ltd (NCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Cathay Pacific Airways Limited:企業の戦略・SWOT・財務分析
    Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Davide Campari-Milano SpA:企業の戦略・SWOT・財務情報
    Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report Summary Davide Campari-Milano SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Kmart Corporation:企業の戦略的SWOT分析
    Kmart Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Cathay Pacific Airways Limited
    Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Cathay Pacific Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (ERYTECH Pharma) is a clinical-stage biopharmaceutical company developing red blood cell-based therapeutics for cancer and orphan diseases. Its pipeline product candidates include erymethionase (methionine-?-lyase), a novel amino acid agent targeting cancer metabolism in so …
  • Monsanto Co (MON):企業の財務・戦略的SWOT分析
    Monsanto Co (MON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Widex AS:企業の戦略的SWOT分析
    Widex AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Exxon Mobil Corporation:企業の戦略・SWOT・財務情報
    Exxon Mobil Corporation - Strategy, SWOT and Corporate Finance Report Summary Exxon Mobil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Fugro NV (FUR):企業の財務・戦略的SWOT分析
    Fugro NV (FUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • BlueRock Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary BlueRock Therapeutics is a biotechnology company that develops novel stem cell therapies to treat cardiovascular and neurodegenerative diseases. The company’s therapeutic candidate is used to treat Parkinson’s disease that restores dopamine production in the midbrain by retaining dopamine-se …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務分析
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Capricor Therapeutics Inc (CAPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Capricor Therapeutics Inc (Capricor) is a biotechnology company that discovers, develops and commercializes biological therapeutics for the treatment of rare disorders. The company offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced …
  • Fabric Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc, is a healthcare solutions provider that offers genome interpretation solutions. The company offers Opal, a cloud-based informatics platform that helps to analyze and interpret genomes by prioritizing disease-causing variants and genes. Fabri …
  • Gentag Inc-医療機器分野:企業M&A・提携分析
    Summary Gentag Inc (Gentag) is a medical device company that patent and develops wireless sensor technology products. The company provides wireless products to personal health and diagnostics. It offers wireless sensor network services. Gentag’s products comprise medication and packaging sensor, imm …
  • Development Bank of Southern Africa:企業の戦略的SWOT分析
    Development Bank of Southern Africa - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • EnGeneIC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆